Evaluation of infrequent dosing regimens with (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine (S-HPMPC) on simian varicella infection in monkeys
- 31 July 1991
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 16 (1) , 17-28
- https://doi.org/10.1016/0166-3542(91)90055-v
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Synthesis and antiviral activity of the nucleotide analog (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cystosineJournal of Medicinal Chemistry, 1989
- (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replicationAntimicrobial Agents and Chemotherapy, 1988
- Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidinesAntiviral Research, 1987
- Novel acyclic adenosine analogs inhibit Epstein-Barr virus replicationAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)-adenine against newly isolated clinical varicella-zoster viras strainsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Synthesis of 9-(2-phosphonylmethoxyethyl)adenine and related compoundsCollection of Czechoslovak Chemical Communications, 1987
- Synthesis of isomeric and enantiomeric O-phosphonylmethyl derivatives of 9-(2,3-dihydroxypropyl)adenineCollection of Czechoslovak Chemical Communications, 1987
- A novel selective broad-spectrum anti-DNA virus agentNature, 1986
- Activity of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil against simian varicella virus infections in African green monkeysAntimicrobial Agents and Chemotherapy, 1986
- Investigation of antiviral activity of 1-β-d-arabinofuranosylthymine (ara-T) and 1-β-d-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-ara-U) in monkeys infected with simian varicella virusAntiviral Research, 1984